A Study of OSI-7904L Versus 5-FU/LV as Treatment in Patients With Biliary Tract Cancer

Mise à jour : Il y a 4 ans
Référence : NCT00088270

Femme et Homme

Extrait

Multi-center, randomized Phase II study to evaluate the efficacy and safety of OSI-7904Lversus 5 FU/LV in biliary tract cancer.


Critère d'inclusion

  • Locally Advanced or Metastatic Adenoca of the Biliary Tract


Liens